{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T20:36:35Z","timestamp":1792182995239,"version":"4.4.0"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2022,6,16]],"date-time":"2022-06-16T00:00:00Z","timestamp":1655337600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,6,16]],"date-time":"2022-06-16T00:00:00Z","timestamp":1655337600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81972689"],"award-info":[{"award-number":["81972689"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81772497"],"award-info":[{"award-number":["81772497"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Mol Med"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1007\/s00109-022-02196-1","type":"journal-article","created":{"date-parts":[[2022,6,16]],"date-time":"2022-06-16T02:02:36Z","timestamp":1655344956000},"page":"1071-1085","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["MyD88 in hepatic stellate cells promotes the development of alcoholic fatty liver via the AKT pathway"],"prefix":"10.1007","volume":"100","author":[{"given":"Yukun","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miaomiao","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9857-3074","authenticated-orcid":false,"given":"Lingling","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinhua","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,6,16]]},"reference":[{"issue":"11","key":"2196_CR1","doi-asserted-by":"publisher","first-page":"2712","DOI":"10.3390\/ijms20112712","volume":"20","author":"LZ Kong","year":"2019","unstructured":"Kong LZ, Chandimali N, Han YH, Lee DH, Kim JS, Kim SU et al (2019) Pathogenesis, Early Diagnosis, and Therapeutic Management of Alcoholic Liver Disease. Int J Mol Sci 20(11):2712","journal-title":"Int J Mol Sci"},{"issue":"1 Suppl","key":"2196_CR2","doi-asserted-by":"publisher","first-page":"S38","DOI":"10.1016\/j.jhep.2015.03.006","volume":"62","author":"P Mathurin","year":"2015","unstructured":"Mathurin P, Bataller R (2015) Trends in the management and burden of alcoholic liver disease. J Hepatol 62(1 Suppl):S38-46","journal-title":"J Hepatol"},{"issue":"4","key":"2196_CR3","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1038\/nrgastro.2015.35","volume":"12","author":"A Louvet","year":"2015","unstructured":"Louvet A, Mathurin P (2015) Alcoholic liver disease: mechanisms of injury and targeted treatment. Nat Rev Gastroenterol Hepatol 12(4):231\u2013242","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"2","key":"2196_CR4","first-page":"147","volume":"38","author":"NA Osna","year":"2017","unstructured":"Osna NA, Donohue Jr TM, Kharbanda KK\u00a0(2017) Alcoholic Liver Disease: Pathogenesis and Current Management. Alcohol Res 38(2):147\u2013161","journal-title":"Alcohol Res"},{"issue":"5","key":"2196_CR5","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1053\/j.gastro.2011.09.002","volume":"141","author":"B Gao","year":"2011","unstructured":"Gao B, Bataller R (2011) Alcoholic liver disease: pathogenesis and new therapeutic targets. Gastroenterology 141(5):1572\u20131585","journal-title":"Gastroenterology"},{"issue":"8","key":"2196_CR6","doi-asserted-by":"publisher","first-page":"1756","DOI":"10.1053\/j.gastro.2016.02.035","volume":"150","author":"LE Nagy","year":"2016","unstructured":"Nagy LE, Ding WX, Cresci G, Saikia P, Shah VH (2016) Linking Pathogenic Mechanisms of Alcoholic Liver Disease With Clinical Phenotypes. Gastroenterology 150(8):1756\u20131768","journal-title":"Gastroenterology"},{"issue":"4","key":"2196_CR7","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1002\/hep.27921","volume":"62","author":"B Chang","year":"2015","unstructured":"Chang B, Xu MJ, Zhou Z, Cai Y, Li M, Wang W et al (2015) Short- or long-term high-fat diet feeding plus acute ethanol binge synergistically induce acute liver injury in mice: an important role for CXCL1. Hepatology 62(4):1070\u20131085","journal-title":"Hepatology"},{"issue":"3","key":"2196_CR8","doi-asserted-by":"publisher","first-page":"226","DOI":"10.2174\/1874467208666150817112109","volume":"10","author":"M You","year":"2017","unstructured":"You M, Jogasuria A, Lee K, Wu J, Zhang Y, Lee YK et al (2017) Signal Transduction Mechanisms of Alcoholic Fatty Liver Disease: Emer ging Role of Lipin-1. Curr Mol Pharmacol 10(3):226\u2013236","journal-title":"Curr Mol Pharmacol"},{"issue":"7","key":"2196_CR9","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1194\/jlr.M056978","volume":"56","author":"J Gu","year":"2015","unstructured":"Gu J, Zhang Y, Xu D, Zhao Z, Zhang Y, Pan Y et al (2015) Ethanol-induced hepatic steatosis is modulated by glycogen level in the liver. J Lipid Res 56(7):1329\u20131339","journal-title":"J Lipid Res"},{"issue":"10","key":"2196_CR10","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1038\/labinvest.2014.98","volume":"94","author":"YJ Choi","year":"2014","unstructured":"Choi YJ, Shin HS, Choi HS, Park JW, Jo I, Oh ES et al (2014) Uric acid induces fat accumulation via generation of endoplasmic reticulum stress and SREBP-1c activation in hepatocytes. Lab Invest 94(10):1114\u20131125","journal-title":"Lab Invest"},{"key":"2196_CR11","doi-asserted-by":"crossref","unstructured":"Greuter T, Malhi H, Gores GJ, Shah VH (2017) Therapeutic opportunities for alcoholic steatohepatitis and nonalcoholic steatohepatitis: exploiting similarities and differences in pathogenesis. JCI Insight 2(17):e95354","DOI":"10.1172\/jci.insight.95354"},{"issue":"9","key":"2196_CR12","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1002\/cbin.10790","volume":"41","author":"de Oliveira da Silva B, Ramos LF, M","year":"2017","unstructured":"de Oliveira da Silva B, Ramos LF, Moraes KCM (2017) Molecular interplays in hepatic stellate cells: apoptosis, senescence, and phenotype reversion as cellular connections that modulate liver fibrosis. Cell Biol Int 41(9):946\u2013959","journal-title":"Cell Biol Int"},{"issue":"1","key":"2196_CR13","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1007\/s00535-017-1404-4","volume":"53","author":"L Shang","year":"2018","unstructured":"Shang L, Hosseini M, Liu X, Kisseleva T, Brenner DA (2018) Human hepatic stellate cell isolation and characterization. J Gastroenterol 53(1):6\u201317","journal-title":"J Gastroenterol"},{"issue":"5","key":"2196_CR14","doi-asserted-by":"publisher","first-page":"1902","DOI":"10.1172\/JCI66369","volume":"123","author":"C Yin","year":"2013","unstructured":"Yin C, Evason KJ, Asahina K, Stainier DY (2013) Hepatic stellate cells in liver development, regeneration, and cancer. J Clin Invest 123(5):1902\u20131910","journal-title":"J Clin Invest"},{"key":"2196_CR15","doi-asserted-by":"crossref","unstructured":"Choi WM, Kim HH, Kim MH, Cinar R, Yi HS, Eun HS et al (2019) Glutamate Signaling in Hepatic Stellate Cells Drives Alcoholic Steatosis. Cell Metab 30(5):877\u201389 e7","DOI":"10.1016\/j.cmet.2019.08.001"},{"issue":"3","key":"2196_CR16","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1021\/acs.bioconjchem.7b00808","volume":"29","author":"J Bob","year":"2018","unstructured":"Bob J, Ignacio TJA, Esser-Kahn AP, Verdoes M (2018) Toll-like Receptor Agonist Conjugation: A Chemical Perspective. Bioconjug Chem 29(3):587\u2013603","journal-title":"Bioconjug Chem"},{"issue":"6","key":"2196_CR17","doi-asserted-by":"publisher","first-page":"7788","DOI":"10.1002\/jcp.27698","volume":"234","author":"OR Tamtaji","year":"2019","unstructured":"Tamtaji OR, Mobini M, Reiter RJ, Azami A, Gholami MS, Asemi Z (2019) Melatonin, a toll-like receptor inhibitor: Current status and future perspectives. J Cell Physiol 234(6):7788\u20137795","journal-title":"J Cell Physiol"},{"key":"2196_CR18","doi-asserted-by":"crossref","unstructured":"Deguine J, Barton GM (2014) MyD88: a central player in innate immune signaling. F1000Prime Rep 6:97","DOI":"10.12703\/P6-97"},{"issue":"4","key":"2196_CR19","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1136\/gutjnl-2015-310904","volume":"66","author":"T Duparc","year":"2017","unstructured":"Duparc T, Plovier H, Marrachelli VG, Van Hul M, Essaghir A, Stahlman M et al (2017) Hepatocyte MyD88 affects bile acids, gut microbiota and metabolome contributing to regulate glucose and lipid metabolism. Gut 66(4):620\u2013632","journal-title":"Gut"},{"issue":"4","key":"2196_CR20","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.cmet.2009.08.013","volume":"10","author":"A Kleinridders","year":"2009","unstructured":"Kleinridders A, Schenten D, Konner AC, Belgardt BF, Mauer J, Okamura T et al (2009) MyD88 signaling in the CNS is required for development of fatty acid-induced leptin resistance and diet-induced obesity. Cell Metab 10(4):249\u2013259","journal-title":"Cell Metab"},{"issue":"1","key":"2196_CR21","doi-asserted-by":"publisher","first-page":"E99","DOI":"10.1152\/ajpendo.00082.2019","volume":"317","author":"MVH Charlotte Lefort","year":"2019","unstructured":"Charlotte Lefort MVH, Delzenne NM, Everard A, Cani PD (2019) Hepatic MyD88 regulates liver inflammation by altering synthesis of oxysterols. Am J Physiol Endocrinol Metab 317(1):E99\u2013E108","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"2196_CR22","doi-asserted-by":"crossref","unstructured":"Bollyky PL, Bice JB, Sweet IR, Falk BA, Gebe JA, Clark AE et al (2009) The toll-like receptor signaling molecule Myd88 contributes to pancreatic beta-cell homeostasis in response to injury. PLoS One 4(4):e5063","DOI":"10.1371\/journal.pone.0005063"},{"issue":"7216","key":"2196_CR23","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1038\/nature07336","volume":"455","author":"L Wen","year":"2008","unstructured":"Wen L, Ley RE, Volchkov PY, Stranges PB, Avanesyan L, Stonebraker AC et al (2008) Innate immunity and intestinal microbiota in the development of Type 1 diabetes. Nature 455(7216):1109\u20131113","journal-title":"Nature"},{"key":"2196_CR24","doi-asserted-by":"publisher","first-page":"5648","DOI":"10.1038\/ncomms6648","volume":"5","author":"A Everard","year":"2014","unstructured":"Everard A, Geurts L, Caesar R, Van Hul M, Matamoros S, Duparc T et al (2014) Intestinal epithelial MyD88 is a sensor switching host metabolism towards obesity according to nutritional status. Nat Commun 5:5648","journal-title":"Nat Commun"},{"issue":"4","key":"2196_CR25","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1111\/acer.13345","volume":"41","author":"H Zhou","year":"2017","unstructured":"Zhou H, Yu M, Roychowdhury S, Sanz-Garcia C, Pollard KA, McMullen MR et al (2017) Myeloid-MyD88 Contributes to Ethanol-Induced Liver Injury in Mice Linking Hepatocellular Death to Inflammation. Alcohol Clin Exp Res 41(4):719\u2013726","journal-title":"Alcohol Clin Exp Res"},{"key":"2196_CR26","doi-asserted-by":"crossref","unstructured":"Hosoi T, Yokoyama S, Matsuo S, Akira S, Ozawa K (2010) Myeloid differentiation factor 88 (MyD88)-deficiency increases risk of diabetes in mice. PLoS One 5(9):e12537","DOI":"10.1371\/journal.pone.0012537"},{"issue":"2","key":"2196_CR27","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1002\/stem.780","volume":"30","author":"D Grcevic","year":"2012","unstructured":"Grcevic D, Pejda S, Matthews BG, Repic D, Wang L, Li H et al (2012) In vivo fate mapping identifies mesenchymal progenitor cells. Stem Cells 30(2):187\u2013196","journal-title":"Stem Cells"},{"issue":"6","key":"2196_CR28","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1136\/gutjnl-2014-308323","volume":"65","author":"K Vlantis","year":"2016","unstructured":"Vlantis K, Polykratis A, Welz PS, van Loo G, Pasparakis M, Wullaert A (2016) TLR-independent anti-inflammatory function of intestinal epithelial TRAF6 signalling prevents DSS-induced colitis in mice. Gut 65(6):935\u2013943","journal-title":"Gut"},{"key":"2196_CR29","doi-asserted-by":"crossref","unstructured":"Yuan Q, Gu J, Zhang J, Liu S, Wang Q, Tian T et al (2021) MyD88 in myofibroblasts enhances colitis-associated tumorigenesis via promoting macrophage M2 polarization. Cell Rep 34(5):108724","DOI":"10.1016\/j.celrep.2021.108724"},{"issue":"11","key":"2196_CR30","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1038\/nn1340","volume":"7","author":"AD Garcia","year":"2004","unstructured":"Garcia AD, Doan NB, Imura T, Bush TG, Sofroniew MV (2004) GFAP-expressing progenitors are the principal source of constitutive neurogenesis in adult mouse forebrain. Nat Neurosci 7(11):1233\u20131241","journal-title":"Nat Neurosci"},{"key":"2196_CR31","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.molimm.2016.05.006","volume":"75","author":"RL McCullough","year":"2016","unstructured":"McCullough RL, McMullen MR, Das D, Roychowdhury S, Strainic MG, Medof ME et al (2016) Differential contribution of complement receptor C5aR in myeloid and non-myeloid cells in chronic ethanol-induced liver injury in mice. Mol Immunol 75:122\u2013132","journal-title":"Mol Immunol"},{"issue":"6","key":"2196_CR32","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1111\/j.1530-0277.2011.01434.x","volume":"35","author":"DJ Orlicky","year":"2011","unstructured":"Orlicky DJ, Roede JR, Bales E, Greenwood C, Greenberg A, Petersen D et al (2011) Chronic ethanol consumption in mice alters hepatocyte lipid droplet properties. Alcohol Clin Exp Res 35(6):1020\u20131033","journal-title":"Alcohol Clin Exp Res"},{"key":"2196_CR33","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/978-1-4939-7113-8_11","volume":"1627","author":"S Weiskirchen","year":"2017","unstructured":"Weiskirchen S, Tag CG, Sauer-Lehnen S, Tacke F, Weiskirchen R (2017) Isolation and Culture of Primary Murine Hepatic Stellate Cells. Methods Mol Biol 1627:165\u2013191","journal-title":"Methods Mol Biol"},{"issue":"8","key":"2196_CR34","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1038\/s41374-018-0067-y","volume":"98","author":"S Hou","year":"2018","unstructured":"Hou S, Jiao Y, Yuan Q, Zhai J, Tian T, Sun K et al (2018) S100A4 protects mice from high-fat diet-induced obesity and inflammation. Lab Invest 98(8):1025\u20131038","journal-title":"Lab Invest"},{"issue":"3","key":"2196_CR35","first-page":"71","volume":"3","author":"XH Xiayu Rao","year":"2013","unstructured":"Xiayu Rao XH, Zhou Z, Lin X (2013) An improvement of the 2^(-delta delta CT) method for quantitative real-time polymerase chain reaction data analysis. Biostat Bioinforma Biomath 3(3):71\u201385","journal-title":"Biostat Bioinforma Biomath"},{"issue":"10","key":"2196_CR36","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1007\/s00109-019-01808-7","volume":"97","author":"Q Yuan","year":"2019","unstructured":"Yuan Q, Hou S, Zhai J, Tian T, Wu Y, Wu Z et al (2019) S100A4 promotes inflammation but suppresses lipid accumulation via the STAT3 pathway in chronic ethanol-induced fatty liver. J Mol Med (Berl) 97(10):1399\u20131412","journal-title":"J Mol Med (Berl)"},{"issue":"8","key":"2196_CR37","doi-asserted-by":"publisher","first-page":"2132","DOI":"10.1007\/s00125-011-2170-0","volume":"54","author":"FW Kiefer","year":"2011","unstructured":"Kiefer FW, Neschen S, Pfau B, Legerer B, Neuhofer A, Kahle M et al (2011) Osteopontin deficiency protects against obesity-induced hepatic steatosis and attenuates glucose production in mice. Diabetologia 54(8):2132\u20132142","journal-title":"Diabetologia"},{"issue":"2","key":"2196_CR38","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1093\/carcin\/bgy173","volume":"41","author":"A Mohs","year":"2020","unstructured":"Mohs A, Kuttkat N, Otto T, Youssef SA, De Bruin A, Trautwein C (2020) MyD88-dependent signaling in non-parenchymal cells promotes liver carcinogenesis. Carcinogenesis 41(2):171\u2013181","journal-title":"Carcinogenesis"},{"issue":"Suppl 1","key":"2196_CR39","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1111\/jgh.12019","volume":"28","author":"YS Roh","year":"2013","unstructured":"Roh YS, Seki E (2013) Toll-like receptors in alcoholic liver disease, non-alcoholic steatohepatitis and carcinogenesis. J Gastroenterol Hepatol 28(Suppl 1):38\u201342","journal-title":"J Gastroenterol Hepatol"},{"issue":"1","key":"2196_CR40","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s00109-016-1474-4","volume":"95","author":"JH Yiu","year":"2017","unstructured":"Yiu JH, Dorweiler B, Woo CW (2017) Interaction between gut microbiota and toll-like receptor: from immunity to metabolism. J Mol Med (Berl) 95(1):13\u201320","journal-title":"J Mol Med (Berl)"},{"issue":"5","key":"2196_CR41","doi-asserted-by":"publisher","first-page":"1742","DOI":"10.1002\/hep.26521","volume":"58","author":"O Morales-Ibanez","year":"2013","unstructured":"Morales-Ibanez O, Dominguez M, Ki SH, Marcos M, Chaves JF, Nguyen-Khac E et al (2013) Human and experimental evidence supporting a role for osteopontin in alcoholic hepatitis. Hepatology 58(5):1742\u20131756","journal-title":"Hepatology"},{"key":"2196_CR42","doi-asserted-by":"crossref","unstructured":"Anthoney N, Foldi I, Hidalgo A (2018) Toll and Toll-like receptor signalling in development. Development 145(9)","DOI":"10.1242\/dev.156018"},{"issue":"10","key":"2196_CR43","doi-asserted-by":"publisher","first-page":"2258","DOI":"10.3390\/cells9102258","volume":"9","author":"KL Diehl","year":"2020","unstructured":"Diehl KL, Vorac J, Hofmann K, Meiser P, Unterweger I, Kuerschner L et al (2020) Kupffer Cells Sense Free Fatty Acids and Regulate Hepatic Lipid Metabolism in High-Fat Diet and Inflammation. Cells 9(10):2258","journal-title":"Cells"},{"key":"2196_CR44","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.clinbiochem.2018.07.003","volume":"59","author":"MA Icer","year":"2018","unstructured":"Icer MA, Gezmen-Karadag M (2018) The multiple functions and mechanisms of osteopontin. Clin Biochem 59:17\u201324","journal-title":"Clin Biochem"},{"issue":"4","key":"2196_CR45","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.aohep.2020.01.001","volume":"19","author":"R Bruha","year":"2020","unstructured":"Bruha R, Vitek L, Smid V (2020) Osteopontin - A potential biomarker of advanced liver disease. Ann Hepatol 19(4):344\u2013352","journal-title":"Ann Hepatol"},{"issue":"36","key":"2196_CR46","doi-asserted-by":"publisher","first-page":"13088","DOI":"10.3748\/wjg.v20.i36.13088","volume":"20","author":"D Seth","year":"2014","unstructured":"Seth D, Duly A, Kuo PC, McCaughan GW, Haber PS (2014) Osteopontin is an important mediator of alcoholic liver disease via hepatic stellate cell activation. World J Gastroenterol 20(36):13088\u201313104","journal-title":"World J Gastroenterol"},{"key":"2196_CR47","doi-asserted-by":"crossref","unstructured":"Lancha A, Rodriguez A, Catalan V, Becerril S, Sainz N, Ramirez B et al (2014) Osteopontin deletion prevents the development of obesity and hepatic steatosis via impaired adipose tissue matrix remodeling and reduced inflammation and fibrosis in adipose tissue and liver in mice. PLoS One 9(5):e98398","DOI":"10.1371\/journal.pone.0098398"},{"issue":"4","key":"2196_CR48","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1002\/hep.26931","volume":"59","author":"X Ge","year":"2014","unstructured":"Ge X, Leung TM, Arriazu E, Lu Y, Urtasun R, Christensen B et al (2014) Osteopontin binding to lipopolysaccharide lowers tumor necrosis factor-alpha and prevents early alcohol-induced liver injury in mice. Hepatology 59(4):1600\u20131616","journal-title":"Hepatology"},{"issue":"3","key":"2196_CR49","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1016\/j.aohep.2019.04.005","volume":"18","author":"JP Arab","year":"2019","unstructured":"Arab JP, Roblero JP, Altamirano J, Bessone F, Chaves Araujo R, Higuera-De la Tijera F et al (2019) Alcohol-related liver disease: Clinical practice guidelines by the Latin American Association for the Study of the Liver (ALEH). Ann Hepatol 18(3):518\u2013535","journal-title":"Ann Hepatol"},{"issue":"36","key":"2196_CR50","doi-asserted-by":"publisher","first-page":"6549","DOI":"10.3748\/wjg.v23.i36.6549","volume":"23","author":"S Singh","year":"2017","unstructured":"Singh S, Osna NA, Kharbanda KK (2017) Treatment options for alcoholic and non-alcoholic fatty liver disease: A review. World J Gastroenterol 23(36):6549\u20136570","journal-title":"World J Gastroenterol"},{"issue":"4","key":"2196_CR51","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/j.cld.2012.08.002","volume":"16","author":"AI Cederbaum","year":"2012","unstructured":"Cederbaum AI (2012) Alcohol metabolism. Clin Liver Dis 16(4):667\u2013685","journal-title":"Clin Liver Dis"},{"issue":"22","key":"2196_CR52","doi-asserted-by":"publisher","first-page":"11865","DOI":"10.1074\/jbc.M115.705541","volume":"291","author":"C Heier","year":"2016","unstructured":"Heier C, Taschler U, Radulovic M, Aschauer P, Eichmann TO, Grond S et al (2016) Monoacylglycerol Lipases Act as Evolutionarily Conserved Regulators of Non-oxidative Ethanol Metabolism. J Biol Chem 291(22):11865\u201311875","journal-title":"J Biol Chem"},{"key":"2196_CR53","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/j.cca.2012.11.014","volume":"415","author":"TM Maenhout","year":"2013","unstructured":"Maenhout TM, De Buyzere ML, Delanghe JR (2013) Non-oxidative ethanol metabolites as a measure of alcohol intake. Clin Chim Acta 415:322\u2013329","journal-title":"Clin Chim Acta"},{"key":"2196_CR54","doi-asserted-by":"crossref","unstructured":"Hugbart C, Verres Y, Le Dare B, Bucher S, Vene E, Bodin A et al (2020) Non-oxidative ethanol metabolism in human hepatic cells in vitro: Involvement of uridine diphospho-glucuronosyltransferase 1A9 in ethylglucuronide production. Toxicol In Vitro 66:104842","DOI":"10.1016\/j.tiv.2020.104842"},{"issue":"1","key":"2196_CR55","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.biocel.2005.07.010","volume":"38","author":"TM Donohue","year":"2006","unstructured":"Donohue TM, Osna NA, Clemens DL (2006) Recombinant Hep G2 cells that express alcohol dehydrogenase and cytochrome P450 2E1 as a model of ethanol-elicited cytotoxicity. Int J Biochem Cell Biol 38(1):92\u2013101","journal-title":"Int J Biochem Cell Biol"},{"issue":"5","key":"2196_CR56","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1002\/hep.20909","volume":"42","author":"NA Osna","year":"2005","unstructured":"Osna NA, Clemens DL, Donohue TM Jr (2005) Ethanol metabolism alters interferon gamma signaling in recombinant HepG2 cells. Hepatology 42(5):1109\u20131117","journal-title":"Hepatology"}],"container-title":["Journal of Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00109-022-02196-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00109-022-02196-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00109-022-02196-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,21]],"date-time":"2022-06-21T05:03:35Z","timestamp":1655787815000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00109-022-02196-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,16]]},"references-count":56,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["2196"],"URL":"https:\/\/doi.org\/10.1007\/s00109-022-02196-1","relation":{},"ISSN":["0946-2716","1432-1440"],"issn-type":[{"value":"0946-2716","type":"print"},{"value":"1432-1440","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,16]]},"assertion":[{"value":"29 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 March 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal studies were performed with the approval of the Institutional Laboratory Animal Care and Use Committee of the Institute of Biophysics, Chinese Academy of Sciences.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent statement"}},{"value":"All human studies have been approved by the appropriate ethics committee. All animal experiment protocols in the manuscript \u201cMyD88 in hepatic stellate cells promotes the development of alcoholic fatty liver via the AKT pathway\u201d (ID: JMME-D-21-00496R2) were approved by the Institutional Laboratory Animal Care and Use Committee of School of Science, Beijing Jiaotong University.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research involving human and animal participants"}},{"value":"The authors declare no conflicts of interest.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interests"}}]}}